Skip to main content
. Author manuscript; available in PMC: 2017 Jan 11.
Published in final edited form as: Obes Surg. 2011 Jun;21(6):722–729. doi: 10.1007/s11695-010-0126-y

Fig. 1.

Fig. 1

The difference in girth loss between placebo and the LAPEX 2000 LipoLaser at treatments 1, 3, and 8 were all 0.4 to 0.5 cm, and the difference in girth loss at treatment 3 was statistically significant (p < 0.05). The difference in cumulative girth loss compared from treatment 1 to 3 was statistically significant by LOCF or completer's analysis (p < 0.05). The difference in cumulative girth loss at treatment 8 was significant in subjects who remained within 1.5 kg of their baseline weights (p < 0.05)